OneSource Specialty Pharma gets GMP certification for flagship unit 2 facility

OneSource Specialty Pharma has received Good Manufacturing Practices (GMP) certification from ANVISA, the Brazilian Health Regulatory Agency, for its flagship Unit 2 facility, following a successful regulatory inspection from November 18, 2024 to November 22, 2024.

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.